Vontobel Holding Ltd. Cel Sci Corp Transaction History

Vontobel Holding Ltd.

  • $28.9 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
BUY
$0.4 - $1.11 $12,000 - $33,300
30,000 Added 300.0%
40,000 $16,000
Q2 2024

Aug 13, 2024
SELL
$1.11 - $1.85 $16,650 - $27,750
-15,000 Reduced 60.0%
10,000 $11,000
Q4 2023

Jan 29, 2024
BUY
$1.07 - $3.07 $26,750 - $76,750
25,000 New
25,000 $68,000

Others Institutions Holding CVM

# of Institutions
60
Shares Held
7.51M
Call Options Held
73.8K
Put Options Held
106K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $341M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email